BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Song JS, Chang CC, Wu CH, Dinh TK, Jan JJ, Huang KW, Chou MC, Shiue TY, Yeh KC, Ke YY, Yeh TK, Ta YN, Lee CJ, Huang JK, Sung YC, Shia KS, Chen Y. A highly selective and potent CXCR4 antagonist for hepatocellular carcinoma treatment. Proc Natl Acad Sci U S A 2021;118:e2015433118. [PMID: 33753481 DOI: 10.1073/pnas.2015433118] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Geh D, Leslie J, Rumney R, Reeves HL, Bird TG, Mann DA. Neutrophils as potential therapeutic targets in hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 2022. [PMID: 35022608 DOI: 10.1038/s41575-021-00568-5] [Reference Citation Analysis]
2 Chen H, Fu Y, Feng K, Zhou Y, Wang X, Huang H, Chen Y, Wang W, Xu Y, Tian H, Mao Y, Wang J, Zhang Z. Polydopamine-coated UiO-66 nanoparticles loaded with perfluorotributylamine/tirapazamine for hypoxia-activated osteosarcoma therapy. J Nanobiotechnology 2021;19:298. [PMID: 34592996 DOI: 10.1186/s12951-021-01013-0] [Reference Citation Analysis]
3 Bule P, Aguiar SI, Aires-Da-Silva F, Dias JNR. Chemokine-Directed Tumor Microenvironment Modulation in Cancer Immunotherapy. Int J Mol Sci 2021;22:9804. [PMID: 34575965 DOI: 10.3390/ijms22189804] [Reference Citation Analysis]